Clinical Trial Update: National Evaluation of PI-based 2nd Line Efficacy in Cambodia

View source ↗

Summary

A completed clinical trial evaluated protease inhibitor–based second-line therapy efficacy for HIV in Cambodia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV | Status: COMPLETED